Be Prepared to Treat Multidrug-Resistant "ESBL" and "CRE" Infections

You'll hear more about treating "superbugs" such as ESBL and CRE...due to a push from the World Health Organization.

Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are popping up everywhere. And most states are reporting carbapenem-resistant Enterobacteriaceae (CRE)...which is fatal in about 50% of cases.

Help prevent progression of superbugs with judicious antibiotic use.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals